New Research Examines Treatment Strategy for Resistant Rosacea

Newswise — Rosacea, a common and disabling skin condition, affects 10 percent of the population worldwide. Symptoms of the chronic inflammatory skin disease may be persistent, and triggered by daily exposures like sun and heat. 

For treatment, global guidelines recommend using oral antibiotics combined with topical anti-inflammatory agents for management. However for many with moderate to severe rosacea, this approach is ineffective and unique therapeutic approaches, including the oral medication isotretinoin, are needed though limited information supporting their use is available.